MANNKIND CORP Earnings Per Share, Basic and Diluted
MANNKIND CORP (MNKD) reported Earnings Per Share, Basic and Diluted of -$0.10 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- MANNKIND CORP earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.10.
- MANNKIND CORP earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.02.
- MANNKIND CORP earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.14.
- MANNKIND CORP earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.05.
- MANNKIND CORP earnings per share, basic and diluted for fiscal 2021 was -$0.32.
- MANNKIND CORP earnings per share, basic and diluted for fiscal 2020 was -$0.26.
- MANNKIND CORP earnings per share, basic and diluted for fiscal 2019 was -$0.27.
- MANNKIND CORP earnings per share, basic and diluted for fiscal 2018 was -$0.60.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.10 10-Q · filed 2022-05-05 | |||||
| 2021-12-31 | -$0.32 10-K · filed 2022-02-24 | |||||
| 2021-09-30 | -$0.02 10-Q · filed 2021-11-09 | -$0.21 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | -$0.14 10-Q · filed 2021-08-11 | -$0.20 10-Q · filed 2021-08-11 | ||||
| 2021-03-31 | -$0.05 10-Q · filed 2022-05-05 | |||||
| 2020-12-31 | -$0.26 10-K · filed 2022-02-24 | |||||
| 2020-09-30 | -$0.05 10-Q · filed 2021-11-09 | -$0.14 10-Q · filed 2021-11-09 | ||||
| 2020-06-30 | -$0.05 10-Q · filed 2021-08-11 | -$0.09 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | -$0.04 10-Q · filed 2021-05-12 | |||||
| 2019-12-31 | -$0.07 10-K · filed 2020-02-25 | -$0.27 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$0.05 10-Q · filed 2020-11-04 | -$0.20 10-Q · filed 2020-11-04 | ||||
| 2019-06-30 | -$0.07 10-Q · filed 2020-08-05 | -$0.15 10-Q · filed 2020-08-05 | ||||
| 2019-03-31 | -$0.08 10-Q · filed 2020-05-06 | |||||
| 2018-12-31 | -$0.06 10-K · filed 2020-02-25 | -$0.60 10-K · filed 2020-02-25 | ||||
| 2018-09-30 | -$0.16 10-K · filed 2020-02-25 | -$0.56 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | -$0.16 10-K · filed 2020-02-25 | -$0.41 10-Q · filed 2019-08-07 | ||||
| 2018-03-31 | -$0.25 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | -$0.31 10-Q · filed 2018-11-01 | -$0.84 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | -$0.35 10-Q · filed 2018-08-02 | -$0.53 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | -$0.17 10-Q · filed 2018-05-09 | |||||
| 2016-06-30 | -$0.33 10-Q · filed 2017-08-07 | -$0.07 10-Q · filed 2016-08-09 | -$0.62 10-Q · filed 2017-08-07 | -$0.12 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | -$0.29 10-Q · filed 2017-05-10 | -$0.06 10-Q · filed 2016-05-09 | ||||
| 2015-12-31 | -$3.30 10-K · filed 2017-03-16 | -$0.66 10-K · filed 2016-03-15 | -$0.91 10-K · filed 2016-03-15 | |||
| 2015-09-30 | -$0.39 10-K · filed 2017-03-16 | -$0.08 10-Q · filed 2015-11-09 | -$0.23 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | -$0.36 10-K · filed 2017-03-16 | -$0.07 10-Q · filed 2015-08-10 | -$0.15 10-Q/A · filed 2016-08-10 | |||
| 2015-03-31 | -$0.38 10-K · filed 2017-03-16 | -$0.08 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | -$0.09 10-K · filed 2016-03-15 | -$0.51 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | -$0.09 10-K · filed 2016-03-15 | -$0.28 derived: net income ÷ weighted average shares · filed 2015-11-09 | -$0.42 10-Q · filed 2015-11-09 | -$0.58 derived: net income ÷ weighted average shares · filed 2016-03-15 | ||
| 2014-06-30 | -$0.19 10-K · filed 2016-03-15 | -$0.33 10-Q · filed 2015-08-10 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-03-15 | -$0.66 derived: net income ÷ weighted average shares · filed 2016-03-15 | ||
| 2014-03-31 | -$0.14 10-K · filed 2016-03-15 | -$0.30 derived: net income ÷ weighted average shares · filed 2016-03-15 | -$0.47 derived: net income ÷ weighted average shares · filed 2016-03-15 | -$0.63 derived: net income ÷ weighted average shares · filed 2016-03-15 | ||
| 2013-12-31 | -$0.16 10-K · filed 2015-03-02 | -$0.33 derived: net income ÷ weighted average shares · filed 2016-03-15 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-03-15 | -$0.64 10-K · filed 2016-03-15 | ||
| 2013-09-30 | -$0.17 10-Q · filed 2014-11-10 | -$0.33 derived: net income ÷ weighted average shares · filed 2014-11-10 | -$0.48 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | -$0.16 10-K · filed 2015-03-02 | -$0.31 10-Q · filed 2014-08-11 | ||||
| 2013-03-31 | -$0.15 10-K · filed 2015-03-02 | |||||
| 2012-12-31 | -$0.23 10-K · filed 2014-03-03 | -$0.94 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$0.22 10-K · filed 2014-03-03 | -$0.71 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | -$0.23 10-K · filed 2014-03-03 | -$0.49 10-Q · filed 2013-08-09 | ||||
| 2012-03-31 | -$0.27 10-K · filed 2014-03-03 | |||||
| 2011-12-31 | -$0.30 10-K · filed 2013-03-18 | -$1.32 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | -$0.31 10-K · filed 2013-03-18 | -$1.02 10-Q · filed 2012-11-09 | ||||
| 2011-06-30 | -$0.37 10-K · filed 2013-03-18 | -$0.71 10-Q · filed 2012-08-09 | ||||
| 2011-03-31 | -$0.34 10-K · filed 2013-03-18 | |||||
| 2010-12-31 | -$1.50 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | -$0.40 10-Q · filed 2011-11-04 | -$1.17 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | -$0.37 10-Q · filed 2011-08-04 | -$0.77 10-Q · filed 2011-08-04 | ||||
| 2009-12-31 | -$2.07 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |